Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

About this funding opportunity

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (U.S.). This NOFO is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025.

Topic areas: Education and Training, Life Sciences and Health, Social Sciences and Humanities, Gender Equality and Diversity.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due Jan 07, 2028. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Public Authorities
• NGOs
• Large Company
• Other
• University
• SME

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs); U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Agency

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) is administered by National Institutes of Health (NIH), listed via Grants.gov.